Wells Fargo
IBIO icon

Wells Fargo’s iBio IBIO Stock Holding History

Wells Fargo’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2 Hold
1
– – ﹤0.01% 7109
2025
Q4 		$2 Sell
1
-3
-75% -$4 ﹤0.01% 7033
2025
Q3 		$3 Buy
4
+3
+300% +$2 ﹤0.01% 6971
2025
Q2 		$1 Hold
1
– – ﹤0.01% 7091
2025
Q1 		$4 Hold
1
– – ﹤0.01% 6890
2024
Q4 		$2 Hold
1
– – ﹤0.01% 6987
2024
Q3 		$2 Hold
1
– – ﹤0.01% 6838
2024
Q2 		$2 Sell
1
-27
-96% -$58 ﹤0.01% 6797
2024
Q1 		$114 Buy
28
+16
+133% +$20 ﹤0.01% 6619
2023
Q4 		$16 Buy
12
+5
+71% +$22 ﹤0.01% 7275
2023
Q3 		$44 Buy
7
+1
+17% +$9 ﹤0.01% 6950
2023
Q2 		$69 Buy
6
+1
+20% +$19 ﹤0.01% 6962
2023
Q1 		$208 Buy
5
+1
+25% +$26 ﹤0.01% 6767
2022
Q4 		$38 Hold
4
– – ﹤0.01% 7097
2022
Q3 		$0 Hold
4
– – ﹤0.01% 6947
2022
Q2 		$0 Sell
4
-255
-98% -$38.3K ﹤0.01% 7091
2022
Q1 		$55K Buy
259
+17
+7% +$3.56K ﹤0.01% 5606
2021
Q4 		$66K Buy
242
+240
+12,000% +$91.5K ﹤0.01% 5838
2021
Q3 		$1K Sell
2
-5
-71% -$3.11K ﹤0.01% 6716
2021
Q2 		$6K Sell
7
-128
-95% -$93.4K ﹤0.01% 6283
2021
Q1 		$104K Sell
135
-461
-77% -$402K ﹤0.01% 5466
2020
Q4 		$314K Buy
596
+260
+77% +$212K ﹤0.01% 4854
2020
Q3 		$341K Buy
336
+95
+39% +$138K ﹤0.01% 4634
2020
Q2 		$268K Buy
241
+239
+11,950% +$156K ﹤0.01% 4734
2020
Q1 		$1K Buy
+2
New +$770 ﹤0.01% 6061
2015
Q3 		– Hold
0
– – – 6304
2015
Q2 		– Hold
0
– – – 6419
2015
Q1 		– Hold
0
– – – 6052
2014
Q4 		– Hold
0
– – – 6014
2014
Q3 		– Hold
0
– – – 6239
2014
Q2 		– Hold
0
– – – 6187
2014
Q1 		– Hold
0
– – – 5957
2013
Q4 		– Hold
0
– – – 5820
2013
Q3 		– Hold
0
– – – 5733
2013
Q2 		– Hold
0
– – – 5635

Other funds holding IBIO

AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Wells Fargo's IBIO Position: Q1 2026 in Review

Wells Fargo held its iBio (IBIO) position steady in Q1 2026 at 1 share worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #7109.

Wells Fargo first reported a position in IBIO in Q1 2020 and has held it in 25 quarters since. The position peaked at $341K in Q3 2020. 52 funds tracked by Wall St. Rank hold IBIO as of Q1 2026.

  • Wells Fargo held 1 share of iBio worth $2 as of Q1 2026.
  • Wells Fargo left its iBio share count unchanged in Q1 2026.
  • iBio made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #7109 holding.
  • Wells Fargo first reported a position in iBio in Q1 2020 and has held it in 25 quarters since.
  • Wells Fargo's iBio position peaked at $341K in Q3 2020.
  • 52 funds tracked by Wall St. Rank held iBio as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.